Akari Therapeutics furnishes investor presentation for conferences

Akari Therapeutics Plc

Investor presentation furnished as Exhibit 99.1 on December 8, 2025.
Presentation intended for use at conferences and meetings by company officers.
No specific financial or pipeline details disclosed in the filing body.
Filing signed by President and CEO Abizer Gaslightwala.

item 7.01 item 9.01

Akari Therapeutics Plc filing history →

Source: SEC EDGAR

accession 0001493152-25-026533

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.